Skip to main content
Premium Trial:

Request an Annual Quote

The BioCommerce Week Index: Jun 30, 2005

BioCommerce Week’s Index to the
Diversified Molecular Biology Tools Companies
Company
Ticker
Current Price
(
June 28, 2005)
Last Price
(
June 21, 2005)
% Change
Agilent
A
23.49
24.68
-4.82
Applied Biosystems
ABI
20.12
20.83
-3.41
BD
BDX
51.95
52.7
-1.42
Beckman
BEC
63.26
66.36
-4.67
Bio-Rad
BIO
59.39
57.54
3.22
Bruker
BRKR
4.11
4.15
-0.96
GE
GE
35.15
36.15
-2.77
Harvard Bio
HBIO
3.15
3.27
-3.67
Invitrogen
IVGN
83.14
78.79
5.52
Molecular Devices
MDCC
21.36
21.25
0.52
PerkinElmer
PKI
18.75
19.37
-3.20
Sigma
SIAL
56.97
56.6
0.65
Stratagene
STGN
8.61
8.64
-0.35
Thermo
TMO
26.75
26.67
0.30
Waters
WAT
37.84
39.4
-3.96
Index Average  
34.27
34.43
-0.46

BCW Index Falls for Fifth Straight Week

The BCW Index, which tracks the stock movement of 15 multi-platform molecular biology tool companies, dropped slightly for the fifth week in a row. Over the five-day trading period ended Tuesday, the Index declined .46 percent to close at $34.27.

Agilent and Beckman Coulter led the losers this past week, dropping 4.82 percent and 4.67 percent, respectively. Invitrogen posted the biggest gains by far, rising 5.52 percent for the week.

In comparison, the Dow Jones Industrial Average fell 1.8 percent and the Nasdaq declined 1 percent for the tracking period. The Nasdaq Biotech Index, however, edged up .2 percent.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.